Where
This is an online event.Advancements in Breast Cancer Management
elsAGENDA:
5:55p - 6 Welcome/Intro
Lindsay Hardley, DO - Breast Surgeon PCI
6p-6:20 Advancements in Breast Cancer Surgery
Lindsay Hardley, DO
6:20-6:40 How Will I Feel on Treatment?
Melanie Clark, MD - Medical Oncology, Breast Care Team - PCI
6:40-7p Are You at a HIgher Than Average Risk for Breast Cancer?
Breck Hunnicutt, MSN, NP-C, CCRC, Survivorship Coordinator - PCI
Objectives:
1. Discuss techniques for wireless localization of breast tumors
2. Describe decision making of sentinel lymph nodes and axillary management
3. Discuss current trial enrollment for axillary lymph node management
4. Describe how adjuvant systemic treatment is selected for early stage hormone positive, HER2 negative breast cancer
5. Discuss supportive medications and "interventions" during chemotherapy
6. Identify common side effects associated with chemotherapy, endocrine therapy, and their management of each
7. Discuss criteria for high risk breast cancer management
8. Identify personal characteristics which increase risk
9. Describe risk reduction strategies
Educational Credit:
Melonie Clark, MD is a consultant for Astrazeneca and Puma Biotechnology. This conflict has been mitigated. No one else involved in the educational content of this activity has any relevant financial interest with an ACCME-defined commercial interest.
- The Fort Wayne Medical Education Program is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.
- The Fort Wayne Medical Education Program designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.